Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Increased expression of long non-coding RNA CCAT2 predicts poorer prognosis in patients with hepatocellular carcinoma.

Fu C, Xu X, Lu W, Nie L, Yin T, Wu D.

Medicine (Baltimore). 2019 Oct;98(42):e17412. doi: 10.1097/MD.0000000000017412.

2.
3.

Prognostic significance of long non-coding RNA PCAT-1 expression in human hepatocellular carcinoma.

Yan TH, Yang H, Jiang JH, Lu SW, Peng CX, Que HX, Lu WL, Mao JF.

Int J Clin Exp Pathol. 2015 Apr 1;8(4):4126-31. eCollection 2015.

4.

High expression of long non-coding RNA ANRIL is associated with poor prognosis in hepatocellular carcinoma.

Hua L, Wang CY, Yao KH, Chen JT, Zhang JJ, Ma WL.

Int J Clin Exp Pathol. 2015 Mar 1;8(3):3076-82. eCollection 2015.

5.

The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis.

Huang S, Qing C, Huang Z, Zhu Y.

Diagn Pathol. 2016 Jun 10;11(1):49. doi: 10.1186/s13000-016-0499-x.

6.

Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.

Gu JX, Zhang X, Miao RC, Xiang XH, Fu YN, Zhang JY, Liu C, Qu K.

World J Gastroenterol. 2019 Jan 14;25(2):220-232. doi: 10.3748/wjg.v25.i2.220.

7.

Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis.

Wang CY, Hua L, Yao KH, Chen JT, Zhang JJ, Hu JH.

Int J Clin Exp Pathol. 2015 Jan 1;8(1):779-85. eCollection 2015.

8.

A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.

Zhu P, Jin J, Liao Y, Li J, Yu XZ, Liao W, He S.

Oncotarget. 2015 Dec 1;6(38):41383-97. doi: 10.18632/oncotarget.5510.

10.

Upregulation of CCAT2 promotes cell proliferation by repressing the P15 in breast cancer.

Deng X, Zhao Y, Wu X, Song G.

Biomed Pharmacother. 2017 Jul;91:1160-1166. doi: 10.1016/j.biopha.2017.05.030. Epub 2017 May 17.

PMID:
28531944
11.

Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.

Lu LL, Sun J, Lai JJ, Jiang Y, Bai LH, Zhang LD.

World J Gastroenterol. 2015 Jun 7;21(21):6649-59. doi: 10.3748/wjg.v21.i21.6649.

12.

High expression of long non-coding RNA CCAT2 indicates poor prognosis of gastric cancer and promotes cell proliferation and invasion.

Wu SW, Hao YP, Qiu JH, Zhang DB, Yu CG, Li WH.

Minerva Med. 2017 Aug;108(4):317-323. doi: 10.23736/S0026-4806.17.04703-6. Epub 2017 Mar 1.

PMID:
28248065
13.

Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma.

Huang CS, Yu W, Cui H, Wang YJ, Zhang L, Han F, Huang T.

Int J Clin Exp Pathol. 2015 Jun 1;8(6):7234-8. eCollection 2015.

14.

Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.

Zhao QJ, Zhang J, Xu L, Liu FF.

World J Gastroenterol. 2018 Aug 14;24(30):3426-3439. doi: 10.3748/wjg.v24.i30.3426.

15.

Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma.

Li BK, Huang PZ, Qiu JL, Liao YD, Hong J, Yuan YF.

Diagn Pathol. 2014 Dec 3;9:226. doi: 10.1186/s13000-014-0226-4.

16.

High expression of microRNA-130b correlates with poor prognosis of patients with hepatocellular carcinoma.

Wang WY, Zhang HF, Wang L, Ma YP, Gao F, Zhang SJ, Wang LC.

Diagn Pathol. 2014 Aug 15;9:160. doi: 10.1186/s13000-014-0160-5.

17.

Down-regulation of long non-coding RNA GAS5-AS1 and its prognostic and diagnostic significance in hepatocellular carcinoma.

Wang Y, Jing W, Ma W, Liang C, Chai H, Tu J.

Cancer Biomark. 2018;22(2):227-236. doi: 10.3233/CBM-170781.

PMID:
29660898
18.

Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.

Zhang MH, Niu H, Li Z, Huo RT, Wang JM, Liu J.

Cancer Biomark. 2018;23(1):33-43. doi: 10.3233/CBM-181277.

PMID:
29991125
19.

Increased expression of LncRNA BANCR and its prognostic significance in human hepatocellular carcinoma.

Zhou T, Gao Y.

World J Surg Oncol. 2016 Jan 12;14(1):8. doi: 10.1186/s12957-015-0757-5.

20.

HOX Antisense lincRNA HOXA-AS2 Promotes Tumorigenesis of Hepatocellular Carcinoma.

Wang F, Yang H, Deng Z, Su Y, Fang Q, Yin Z.

Cell Physiol Biochem. 2016;40(1-2):287-296. Epub 2016 Nov 18.

Supplemental Content

Support Center